Incoming and outgoing links Tyrosine kinase inhibitors
Back to articleIncoming links
- Afatinib
- Canities (overview)
- Cetuximab
- Dasatinib
- Egf receptors
- Egfr gene
- Erlotinib
- Exanthema, acneiformes
- Exfoliation areata linguae
- Folliculitis perforating
- Folliculitis superficial
- Gefitinib
- Hypereosinophilia syndrome
- Imatinib
- Milia
- Milia multiple eruptive
- Multi-kinase inhibitors
- Sorafenib
- Stevens-johnson syndrome
- Tyrosine kinases
- Vegf
- Vemurafenib
Outgoing links
- Acne medicamentosa
- Afatinib
- Autocrine secretion
- Cetuximab
- Dasatinib
- Dermatofibrosarcoma protuberans (overview)
- Egf receptors
- Eosinophilia and skin
- Epidermal growth factor
- Erlotinib
- Gefitinib
- Gemcitabine
- Glucorticosteroids topical
- Growth factors
- Hand-foot syndrome
- Her2
- Hypereosinophilia syndrome
- Hypertrichoses
- Imatinib
- KIT gene
- Melanoma acrolentiginous
- Melanoma cutaneous
- Monoclonal antibodies
- Mucous membrane melanoma
- Off-label use
- Orphan medicinal products
- Panitumumab
- PDGFR
- Rosacea
- Scleroderma systemic
- Sorafenib
- Tyrosine kinases
- Urea (overview)
- Vegf
- Vemurafenib